個股熱度排行 | 10月26日港股收盤
根據uSMART輿情監測數據,26日港股交易時段,市場關注指數最高的5只股票是騰訊控股、美團-W、康希諾生物、渣打集團、阿裏健康。
10月26日—港股關注排行TOP5

騰訊控股

關注度第一爲騰訊控股,該股今日收盤上漲2.52%,報於211.60港元。近5個交易日累計下跌13.28%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
10月25日uSMART交易熱榜
港股午評:恆指漲2% 恆生科技指數升近4%接近3000點 騰訊漲4%
美團-W

關注度第二爲美團-W,該股今日收盤上漲5.02%,報於129.70港元。近5個交易日累計下跌10.24%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
美團-W早盤漲幅擴大至8.74% 據報在港招聘
美團大漲近9% 開始招聘香港業務人員
康希諾生物

關注度第三爲康希諾生物,該股今日收盤上漲20.60%,報於64.10港元。近5個交易日累計上漲39.05%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
康希諾生物早盤漲逾14% 其吸入式新冠疫苗上海接種
生物醫療板塊全線走強 康希諾生物漲14.86%
渣打集團

關注度第四爲渣打集團,該股今日收盤上漲2.66%,報於50.20港元。近5個交易日累計上漲1.21%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
渣打午後拉昇5.42% 第三季度業績高於預期
渣打集團升6% Q3經調整溢利、收入均好於市場預期
阿裏健康

關注度第五爲阿裏健康,該股今日收盤上漲8.81%,報於3.58港元。近5個交易日累計上漲1.99%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有:
高盛:阿裏健康扭虧較預期早 評級「中性」
招商證券:維持阿裏健康“增持”評級 目標價9.8港元
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.